163 related articles for article (PubMed ID: 31034939)
1. Urinary bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
Loose M; Naber KG; Hu Y; Coates A; Wagenlehner FME
Int J Antimicrob Agents; 2019 Jul; 54(1):55-61. PubMed ID: 31034939
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
Loose M; Naber KG; Hu Y; Coates A; Wagenlehner FME
Int J Antimicrob Agents; 2018 Dec; 52(6):783-789. PubMed ID: 30138665
[TBL] [Abstract][Full Text] [Related]
3. Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant
Hu Y; Liu Y; Coates A
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373798
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
Li Y; Lin X; Yao X; Huang Y; Liu W; Ma T; Fang B
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224527
[TBL] [Abstract][Full Text] [Related]
5. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X
J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565
[TBL] [Abstract][Full Text] [Related]
7. Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.
Straubinger M; Blenk H; Naber KG; Wagenlehner FM
Antimicrob Agents Chemother; 2016 Jun; 60(6):3309-15. PubMed ID: 26976871
[TBL] [Abstract][Full Text] [Related]
8.
Cebrero-Cangueiro T; Álvarez-Marín R; Labrador-Herrera G; Smani Y; Cordero-Matía E; Pachón J; Pachón-Ibáñez ME
Front Cell Infect Microbiol; 2018; 8():363. PubMed ID: 30406040
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
[TBL] [Abstract][Full Text] [Related]
10. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
11. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
Zhou YF; Tao MT; Feng Y; Yang RS; Liao XP; Liu YH; Sun J
J Antimicrob Chemother; 2017 Jun; 72(6):1723-1730. PubMed ID: 28333193
[TBL] [Abstract][Full Text] [Related]
12. Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model.
Yu Y; Walsh TR; Yang RS; Zheng M; Wei MC; Tyrrell JM; Wang Y; Liao XP; Sun J; Liu YH
J Antimicrob Chemother; 2019 Jan; 74(1):87-95. PubMed ID: 30346547
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals.
Falagas ME; Voulgaris GL; Tryfinopoulou K; Giakkoupi P; Kyriakidou M; Vatopoulos A; Coates A; Hu Y;
Int J Antimicrob Agents; 2019 Jun; 53(6):855-858. PubMed ID: 30836109
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of eugenol with Colistin against clinical isolated Colistin-resistant
Wang YM; Kong LC; Liu J; Ma HX
Antimicrob Resist Infect Control; 2018; 7():17. PubMed ID: 29423192
[TBL] [Abstract][Full Text] [Related]
15. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
Elife; 2021 Apr; 10():. PubMed ID: 33821795
[TBL] [Abstract][Full Text] [Related]
16. Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption.
Loose M; Naber KG; Shields P; Reinhart H; Wagenlehner FME
Int J Antimicrob Agents; 2018 Mar; 51(3):422-426. PubMed ID: 29158143
[TBL] [Abstract][Full Text] [Related]
17. The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments.
Albur MS; Noel A; Bowker K; MacGowan A
Int J Antimicrob Agents; 2015 Nov; 46(5):560-7. PubMed ID: 26387065
[TBL] [Abstract][Full Text] [Related]
18. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
19. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
20. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
